1046447-90-8,MFCD28502028
Catalog No.:AA01EN57

1046447-90-8 | JNJ-39758979

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
98%
in stock  
$132.00   $93.00
- +
25mg
98%
in stock  
$291.00   $204.00
- +
100mg
95%
in stock  
$474.00   $332.00
- +
250mg
95%
in stock  
$895.00   $627.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA01EN57
Chemical Name:
JNJ-39758979
CAS Number:
1046447-90-8
Molecular Formula:
C11H19N5
Molecular Weight:
221.3021
MDL Number:
MFCD28502028
SMILES:
N[C@@H]1CCN(C1)c1cc(nc(n1)N)C(C)C
Properties
Computed Properties
 
Complexity:
232  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
16  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.7  

Downstream Synthesis Route
Literature

Title: International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Journal: Pharmacological reviews 20150701

Title: Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.

Journal: The Journal of dermatology 20150201

Title: The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.

Journal: The Journal of pharmacology and experimental therapeutics 20140701

Title: Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979.

Journal: The Journal of pharmacology and experimental therapeutics 20140501

Title: Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.

Journal: Journal of medicinal chemistry 20140327

Title: Savall BM, et al. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H4 receptor antagonists. J Med Chem. 2014 Mar 27;57(6):2429-39.

Title: Murata Y, et al. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:1046447-90-8 Molecular Formula|1046447-90-8 MDL|1046447-90-8 SMILES|1046447-90-8 JNJ-39758979
Catalog No.: AA01EN57
1046447-90-8,MFCD28502028
1046447-90-8 | JNJ-39758979
Pack Size: 5mg
Purity: 98%
in stock
$132.00 $93.00
Pack Size: 25mg
Purity: 98%
in stock
$291.00 $204.00
Pack Size: 100mg
Purity: 95%
in stock
$474.00 $332.00
Pack Size: 250mg
Purity: 95%
in stock
$895.00 $627.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA01EN57
Chemical Name: JNJ-39758979
CAS Number: 1046447-90-8
Molecular Formula: C11H19N5
Molecular Weight: 221.3021
MDL Number: MFCD28502028
SMILES: N[C@@H]1CCN(C1)c1cc(nc(n1)N)C(C)C
Properties
Complexity: 232  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 1  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 16  
Hydrogen Bond Acceptor Count: 5  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.7  
Downstream Synthesis Route
Literature fold

Title: International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors.

Journal: Pharmacological reviews20150701

Title: Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.

Journal: The Journal of dermatology20150201

Title: The histamine H₄ receptor antagonist, JNJ 39758979, is effective in reducing histamine-induced pruritus in a randomized clinical study in healthy subjects.

Journal: The Journal of pharmacology and experimental therapeutics20140701

Title: Clinical and preclinical characterization of the histamine H(4) receptor antagonist JNJ-39758979.

Journal: The Journal of pharmacology and experimental therapeutics20140501

Title: Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H₄ receptor antagonists.

Journal: Journal of medicinal chemistry20140327

Title: Savall BM, et al. Discovery and SAR of 6-alkyl-2,4-diaminopyrimidines as histamine H4 receptor antagonists. J Med Chem. 2014 Mar 27;57(6):2429-39.

Title: Murata Y, et al. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis.

Building Blocks More >
447459-51-0
447459-51-0
N-[(1S)-1-[4-[[4-Methoxy-2-[(4-methoxyphenyl)sulfonyl]phenyl]sulfonyl]phenyl]ethyl]methanesulfonamide
AA01ENFM | MFCD09832651
544707-20-2
544707-20-2
4-[3-[4-[Piperidinyl]but-1-ynyl]benzyl]morpholinedihydrochloride
AA01ENIM
1017682-66-4
1017682-66-4
(3R)-3-Amino-4-(6,7-difluoro-1H-indazol-3-yl)-1-[5,6-dihydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazin-7(8H)-yl]-1-butanonephosphate
AA01ENLY
122517-78-6
122517-78-6
17-(Cyclopropylmethyl)-6,7-didehydro-3,14β-dihydroxy-4,5α-epoxy-6,7-2',3'-benzo[b]furanomorphinanmesylate
AA01ENP3 | MFCD00673953
1820684-31-8
1820684-31-8
M443
AA01ENZS | MFCD31692382
1431303-72-8
1431303-72-8
ORY-1001(trans)
AA01EO33 | MFCD28502247
1797406-80-4
1797406-80-4
E3 ligase Ligand-Linker Conjugates 12
AA01EO6O | MFCD31807299
618913-30-7
618913-30-7
AZD5904
AA01EOD0 | MFCD31619279
1636881-61-2
1636881-61-2
Mavoglurant racemate
AA01EOJG | MFCD30534423
861139-16-4
861139-16-4
RSV-IN-1
AA01EOO9 | MFCD05683760
Submit
© 2017 AA BLOCKS, INC. All rights reserved.